Glatiramer acetate

Details

Files

Generic Name:

Glatiramer acetate

Project Status:

Complete

Therapeutic Area:

Clinically Isolated Syndrome (CIS), suggestive of Multiple Sclerosis

Manufacturer:

Teva Pharmaceutical Industries Ltd.

Brand Name:

Copaxone

Project Line:

Reimbursement Review

Project Number:

SR0164-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Clinically Isolated Syndrome (CIS), suggestive of Multiple Sclerosis

Recommendation Type:

Do not list

Final Recommendation:

November 25, 2009

Last Updated : April 29, 2009